NASDAQ:SHC

Sotera Health Company Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy SHC

*Your capital is at risk

$15.74

-0.0800 (-0.506%)

At Close: Jun 22, 2026

Sotera Health Company Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -99.53. In total, the insiders bought 2.68M and sold 144.48M SHC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-99.53
● Buy	2.68M shares
● Sell	144.48M shares
61% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence May 26, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -99.53. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Simon, Christopher Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Simon, Christopher Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Chen Ruoxi Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Cunningham Sean Laurence Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Klee Ann R. Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Mihas Constantine S Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Neary James Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Petrella Vincent K Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Wheadon David E. Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Knauss Robert Brown Director	Director	19 132 Value: $234.6K
May 22, 2025 Buy	Common Stock, $0.01 par value per share ("Common Stock") A-Award	Flynn Karen Director	Director	19 132 Value: $234.6K
Mar 03, 2025 Buy	Common Stock A-Award	Petras Michael B. Jr. Chairman & CEO	CEO / President	298 953 Value: $3.49M
Mar 03, 2025 Buy	Performance Stock Units A-Award	Petras Michael B. Jr. Chairman & CEO	CEO / President	149 476 Value: $1.75M
Mar 03, 2025 Buy	Common Stock A-Award	Rutz Michael P President Of Sterigenics	CEO / President	48 579 Value: $567.4K
Mar 03, 2025 Buy	Performance RSUs A-Award	Rutz Michael P President Of Sterigenics	CEO / President	24 289 Value: $283.7K
Mar 03, 2025 Buy	Common Stock A-Award	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	37 369 Value: $436.5K
Mar 03, 2025 Buy	Common Stock A-Award	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	59 790 Value: $698.3K
Mar 03, 2025 Buy	Performance RSUs A-Award	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	29 895 Value: $349.2K
Mar 02, 2025 Sell	Common Stock, $0.01 par value per share ("Common Stock") F-InKind	Petras Michael B. Jr. Chairman & CEO	CEO / President	27 990 Value: $349.0K
Mar 02, 2025 Sell	Common Stock F-InKind	Petras Michael B. Jr. Chairman & CEO	CEO / President	31 872 Value: $397.4K
Mar 02, 2025 Sell	Common Stock F-InKind	Petras Michael B. Jr. Chairman & CEO	CEO / President	40 987 Value: $511.1K
Mar 02, 2025 Sell	Common Stock, $0.01 par value per share ("Common Stock") F-InKind	Rutz Michael P President Of Sterigenics	CEO / President	3 687 Value: $46.0K
Mar 02, 2025 Sell	Common Stock F-InKind	Rutz Michael P President Of Sterigenics	CEO / President	4 198 Value: $52.3K
Mar 02, 2025 Sell	Common Stock F-InKind	Rutz Michael P President Of Sterigenics	CEO / President	5 399 Value: $67.3K
Mar 02, 2025 Sell	Common Stock, $0.01 par value per share ("Common Stock") F-InKind	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	6 481 Value: $80.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SOTERA HEALTH COMPANY

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricul...

Read Full Profile Here